Long-term outcome of deep venous thrombosis during pregnancy treated with unfractionated heparin or low molecular weight heparin

By Ulander V.-M.   Lehtola A.   Kaaja R.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 239-242

Elsevier

Access to resources Recommend Favorite

Low-molecular-weight heparin vs. a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

By Lee A.Y.Y.   Levine M.N.   Baker R.I.   for the Randomized Comparison of Low-Molecular-Weight Heparin vs. Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer CLOT Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 19-20

Elsevier

Access to resources Recommend Favorite

Anti-thrombotic Efficacies of Enoxaparin, Dalteparin, and Unfractionated Heparin in Venous Thrombo-embolism

By Morris T.A.   Marsh J.J.   Konopka R.   Pedersen C.A.   Chiles P.G.  

Thrombosis Research, Vol. 100, Iss. 3, 2000-11 ,pp. : 185-194

Elsevier

Access to resources Recommend Favorite

VERY LOW DOSES OF UNFRACTIONATED HEPARIN POTENTIATE THE ANTI-Xa ACTIVITY OF LOW MOLECULAR WEIGHT HEPARIN (ENOXAPARIN)

By Perez-Requejo J.L.   Lucena-Solano O.   Perez-Garcia M.   Santarelli M.T.  

Thrombosis Research, Vol. 85, Iss. 3, 1997-02 ,pp. : 259-265

Elsevier

Access to resources Recommend Favorite

Low-molecular-weight heparin compared with unfractionated heparin for patients with non–ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: Results from the CRUSADE initiative

By Singh Kanwar   Roe Matthew   Peterson Eric   Chen Anita   Mahaffey Kenneth   Goodman Shaun   Harrington Robert   Smith Sidney   Gibler W.   Ohman E.   Pollack Charles  

Journal of Thrombosis and Thrombolysis, Vol. 21, Iss. 3, 2006-06 ,pp. : 211-220

Springer Publishing Company

Access to resources Recommend Favorite